Moderna
Moderna Inc. stock - "The end of a pandemic Stock" Moderna, a drugmaker with just a single product to its name
, has become perhaps the best-known biotech in the world over the past four months, with nearly 100 million doses of its Covid-19 vaccine administered in the U.S. alone.
Shares of Moderna Inc. MRNA, +5.56% slid 9.72% to $111.40 Monday, on what proved to be an all-around favourable
trading session for the stock market, with the NASDAQ Composite Index
#moderna #mrna #Mrna
MRNA & end of the bulls?MRNA has had a few wild weeks going up from $120 to $170.
I believe this could be the end of the bullishness and it may do a correction.
Why do I believe this could happen?
MRNA hit historic resistance of $170, after hitting that mark it began dropping. This resistance seems like it can hold.
RSI is bounced off the 70 mark on the daily chart.
RSI is overbought on the 4HR chart
EMA's are beginning to cross over on the hour charts.
This could be a tiny correction and just bounce off $160 before continuing its path to $200 so I would keep a close eye on the stock.
What I am looking for right now is:
1st support - $160
2nd support - $139_$145
3rd support - $120
At this point MRNA going back down to $100 or even lower seems incredibly unlikely.
Moderna's earnings arent too far away so that could act as a catalyzer that will continue the growth.
In short I believe that MRNA could have hit the resistance and it will either go down to the listed supports or if it stays in these levels then it will most likely stay like this till earnings come which will tell what direction it is going to go from here.
Please comment down your ideas and thoughts on this, I would appreciate any criticism you may have on the charts and analysis, and looking forward to your comments!
I am not a financial advisor, these are my personal ideas an thoughts please do your own research before buying a stock.
Trading Idea - ModernaBUY!
Target Order: 148.48 EUR
Stop Order: 120.03 EUR
1.) GoodNEWS for Moderna: The British government wants to continue its course in the fight against the coronavirus. The first deliveries from the pharmaceutical company Moderna are expected in April, told member Oliver Dowden today. It would be the third vaccine to be used in the UK. To date, more than 30 million adults - 57% - have received a first dose.
2.) M30 chart shows a support level at the current price range. A rejection is expected.
3.) Execute the trade based on the recommended TP and SL levels!
4.) SL below last significant low!
Don't fomo into MRNA...yetMRNA made a huge leap on Friday going front $133 to $144.
I believe MRNA will resume bullishnes as long as the market remains stable and bullish BUT, MRNA could drop to around $135 before continuing to go up.
It still has a way to go on the RSI indicator and EMA's still haven't passed over. If MRNA exists the channel be ready for more mooning to come.
Disclaimer: I am not a financial advisor and this is purely my opinion and thought about this stock, do your own research before going into MRNA.
MRNA going back to $120, entered downard channel trend!MRNA seems to have entered another downward channel trend.
Using the previous resistance on the last downward channel trend we can see it can act as a sort of support, the trend also made two other downward resistances as you can see on the chart.
This makes me to believe that this could go back down to $120 where it can make a double bottom which can be a great buying opportunity, but for now, I'm bearish.
MRNA going back down to $120?As mentioned in my last analysis, Monday will be the deal-breaker for MRNA again, and it failed to hold that resistance.
Using historic data this will most likely drop down to $120 again before going back up to the $130s so this can be a great swing trade.
BUT! Watch out for support at $126, using the previous downward channel trend resistance this can act as support so watch out for that.
Reasons for bearishness:
-Historic data of the resistance and dip (influenced the most)
-EMA's crossing right now
-RSI was oversold
It's a clear bearish sign that probably won't last for long so look for a nice swing trade here.
(I am not a financial advisor)
MRNA jumps after hitting support, whats next?For this analysis, I am going to be using the same downward trend channel that I made on March 25th and it went exactly as expected. This recent spike might be coming to an end though due to being overbought on the RSI and close to hitting the resistance on the trend channel.
Although if it breaks through that resistance it can become support, keep an eye on MRNA. If it doesn't break through then it could go back to the $120s level.
MRNA Moderna vs PFE Pfizer | Head and Shoulders patternIf you haven`t longed Moderna with me from here:
Then you should realize that the head an shoulders pattern on descending volume of a company that worth 53.402B, but has 747Mil negative earnings for 2020, may lead to $100 per share.
On the other hand, undervalued, it`s Pfizer , which has the same amazing results with the vaccine, lots of medicine in the portfolio, a market cap almost 4 times higher, 198.973B and positive earnings of 9.62Bil. The pay also great dividends, btw, 4.38% DIV YIELD on a decent 20.82 P/E ratio .
If you are interested to test some amazing BUY and SELL INDICATORS which give the signal at the beginning of the candle, not at the end of it, just leave me a message.
MRNA Upside PotentialModerna has been forming a hidden bullish divergence for the past 5 months (clearly seen on the daily chart, will also post a screenshot in the comments). On the macro-level, we can see a pennant forming with strongly confirmed resistance and support. On the micro-level, we have a clear cup and handle, and currently the price seats at the support of the handle, in 3h demand, and also at a strong key level 135-136, that MRNA always reacted to in the past.
If Moderna confirms the cup and handle by breaking the resistance, would love to add to my long position. However, if it can not hold 135-136, will look to exit and reenter at the macro support ~129.
*The idea above is my own opinion and does not serve as any kind of investment advice. Please do your own due diligence.*